Dexlansoprazole MR in Nonerosive Reflux Disease

Soon Chun Hyang University

Status: Unknown

Conditions: Nonerosive Reflux Disease

Treatments: Drug: Dexlansoprazole MR

Study type: Interventional

Funder types: Other

Identifiers

NCT02490449

SCHBC 2014-05-021-002

Details and patient eligibility

About

This study aim is to compare the efficacy of Dexlansoprazole MR intake before and after breakfast in patients with nonerosive reflux disease.

Enrollment: 356 estimated patients

Sex: All

Ages: 19 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• NERD confirmed by gastroscopy

Exclusion criteria

• PPI medication within 2 weeks before enrollment

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

356 participants in 2 patient groups

Exprerimental group

Experimental group

Description:

medication after diet

Treatment:

Drug: Dexlansoprazole MR

control group

Active Comparator group

Description:

medication before diet

Treatment:

Drug: Dexlansoprazole MR